A Phase III Parallel Group Study, Comparing the Efficacy, Safety and Tolerability of the Fixed Dose Combination (FDC) of Fluticasone Furoate+Umeclidinium Bromide+Vilanterol (FF/UMEC/VI) With the FDC of FF/VI in Subjects With Inadequately Controlled Asthma
Condition:   Asthma Interventions:   Drug: FF/UMEC/VI (100/31.25/25) mcg;   Drug: FF/UMEC/VI (100/62.5/25) mcg;   Drug: FF/UMEC/VI (200/31.25/25) mcg;   Drug: FF/UMEC/VI (200/62.5/25) mcg;   Drug: FF/VI (100/25) mcg;   Drug: FF/VI (200/25) mcg;   Drug: Fluticasone/salmeterol (FSC);   Drug: Albuterol/salb utamol Sponsor:   GlaxoSmithKline Not yet recruiting - verified October 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 12, 2016 Category: Research Source Type: clinical trials

A Phase III Parallel Group Study, Comparing the Efficacy, Safety and Tolerability of the Fixed Dose Combination (FDC) of Fluticasone Furoate+Umeclidinium Bromide+Vilanterol (FF/UMEC/VI) With the FDC of FF/VI in Subjects With Inadequately Controlled Asthma
Condition:   Asthma Interventions:   Drug: FF/UMEC/VI (100/31.25/25) mcg;   Drug: FF/UMEC/VI (100/62.5/25) mcg;   Drug: FF/UMEC/VI (200/31.25/25) mcg;   Drug: FF/UMEC/VI (200/62.5/25) mcg;   Drug: FF/VI (100/25) mcg;   Drug: FF/VI (200/25) mcg;   Drug: Fluticasone/salmeterol (FSC);   Drug: Albuterol/salb utamol;   Device: ELLIPTA DPI;   Device: DISKUS DPI;   Device: METERED-DOSE INHALER (MDI) Sponsor:   GlaxoSmithKline No...
Source: ClinicalTrials.gov - September 12, 2016 Category: Research Source Type: clinical trials

Inhaled Beta-adrenergic Agonists to Treat Pulmonary Vascular Disease in Heart Failure With Preserved EF (BEAT HFpEF): A Randomized Controlled Trial
Conditions:   Congestive Heart Failure;   Heart Failure, Left-Sided;   Left-Sided Heart Failure Interventions:   Drug: Albuterol;   Other: Saline placebo Sponsor:   Mayo Clinic Not yet recruiting - verified August 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 24, 2016 Category: Research Source Type: clinical trials

Inhaled Beta-adrenergic Agonists to Treat Pulmonary Vascular Disease in Heart Failure With Preserved EF (BEAT HFpEF): A Randomized Controlled Trial
Conditions:   Congestive Heart Failure;   Heart Failure, Left-Sided;   Left-Sided Heart Failure Interventions:   Drug: Albuterol;   Other: Saline placebo Sponsor:   Mayo Clinic Recruiting - verified August 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 24, 2016 Category: Research Source Type: clinical trials

Phase I, Placebo-Controlled, Blinded Pilot Study of Ipratropium in Children Admitted to the ICU With Status Asthmaticus
Condition:   Status Asthmaticus Interventions:   Drug: Ipratropium;   Drug: 0.9% Sodium Chloride;   Drug: Albuterol;   Drug: corticosteroids Sponsor:   University Hospital Case Medical Center Not yet recruiting - verified August 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 16, 2016 Category: Research Source Type: clinical trials

Change in Oxygen Consumption Following Inhalation Beta Agonists in Healthy Adults
Condition:   Oxygen ConsumptionInterventions:   Drug: Albuterol;   Drug: LevalbuterolSponsor:   Children's Hospital Los AngelesEnrolling by invitation - verified June 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 10, 2016 Category: Research Source Type: clinical trials

An Efficacy Study of Umeclidinium/Vilanterol With Tiotropium/Olodaterol in COPD Patients
Condition:   Pulmonary Disease, Chronic ObstructiveInterventions:   Drug: UMEC/VI;   Drug: TIO/OLO;   Drug: Albuterol/salbutamolSponsor:   GlaxoSmithKlineNot yet recruiting - verified June 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 2, 2016 Category: Research Source Type: clinical trials